Headlands Technologies’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,150	Closed	-$471K	–	1124
2024 Q1	$471K	Buy	+3,150	New	+$471K	0.11%	203
2023 Q4	–	Sell	-1,146	Closed	-$203K	–	939
2023 Q3	$203K	Sell	1,146 -1,518	-57%	-$269K	0.1%	200
2023 Q2	$506K	Buy	+2,664	New	+$506K	0.16%	153